Biosimilar Interchangeability
Biosimilar Interchangeability" refers to the ability of a biosimilar product to be substituted for the reference biologic product without any negative impact on safety or efficacy. This is a critical concept in the field of biopharmaceuticals and regulatory agencies around the world have established guidelines and criteria to determine whether a biosimilar can be considered interchangeable with its reference product. Here's some content about biosimilar interchangeability
Related Conference of Biosimilar Interchangeability
October 13-14, 2025
17th International Conference on Tissue Science and Regenerative Medicine
Rome, Italy